What is the usual usage period of Opicapone?

Opicapone is a long-acting peripheral catechol-O-methyltransferase (COMT) inhibitor, which is used in combination with levodopa to treat the "switch phenomenon" that occurs in patients with Parkinson's disease in the middle and late stages, that is, motor fluctuations in which the "on period" is shortened and the "off period" is prolonged. Its therapeutic mechanism is to delay the peripheral metabolism of levodopa and increase its concentration into the central nervous system, thereby enhancing and prolonging its anti-Parkinson's disease effect. Due to Opicapone's high enzyme binding ability and long-term enzyme inhibition, its efficacy is far superior to that of previous COMT inhibitors, such as Entacapone, and it enables the convenience of administration only once a day.

As for the usage cycle of Opicapone, there is currently no fixed treatment duration limit. Generally, Opicapone is used as a long-term maintenance treatment drug, continuously used in combination with levodopa. After patients use Opicapone, the therapeutic effects usually begin to appear within a few days, especially the significant shortening of the "off period" and the prolongation of the "on period". According to the BIPARK series of research data, most patients can feel symptoms improve after taking the medicine for 1 to 2 weeks, and achieve a more stable motor control state after several months of continuous use. Therefore, there is no need to set a clear time point for discontinuation before adverse reactions occur or disease progression occurs.

However, although Opicapone is suitable for long-term use, clinicians will still conduct periodic assessments based on the patient's individual response, occurrence of adverse events, and disease progression to decide whether to continue, adjust the dose, or change the treatment plan. Therefore, although Opicapone is a drug designed for long-term treatment, its actual use period should be adjusted individually under the guidance of a physician.

Reference materials:https://www.ongentys.com/